Sheldon Bradshaw was appointed General Counsel in 2024. He has extensive experience in FDA regulatory law and life sciences. Previously, he was a partner at the Washington, D.C. office of King & Spalding, where he specialized in FDA and life sciences practice. From 2005 to 2007, he served as Chief Counsel at the U.S. Food and Drug Administration, where he advised senior leadership on regulatory and compliance matters within the U.S. Department of Health and Human Services.